Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey M Granja

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Nature Communications|May 21, 2021
High-throughput single-cell chromatin accessibility CRISPR screens enable unbiased identification of regulatory networks in cancerSarah E Pierce, Jeffrey M Granja, William J Greenleaf
The Journal of Investigative Dermatology|October 14, 2018
Enhancer Connectome Nominates Target Genes of Inherited Risk Variants from Inflammatory Skin DisordersMark Y Jeng, Maxwell R Mumbach, Jeffrey M Granja, et al.
Nature Genetics|February 26, 2021
ArchR is a scalable software package for integrative single-cell chromatin accessibility analysisJeffrey M Granja, M Ryan Corces, Sarah E Pierce, et al.
Cell Reports|September 23, 2020
Chromatin Landscape Underpinning Human Dendritic Cell HeterogeneityRebecca Leylek, Marcela Alcántara-Hernández, Jeffrey M Granja, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2022
Polycomb-mediated genome architecture enables long-range spreading of H3K27 methylationKaterina Kraft, Kathryn E Yost, Sedona E Murphy, et al.
Nature Biotechnology|December 4, 2019
Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemiaJeffrey M Granja, Sandy Klemm, Lisa M McGinnis, et al.
Nature Cell Biology|August 3, 2021
LKB1 inactivation modulates chromatin accessibility to drive metastatic progressionSarah E Pierce, Jeffrey M Granja, M Ryan Corces, et al.
Nature Immunology|August 14, 2019
An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 developmentPrachi Bagadia, Xiao Huang, Tian-Tian Liu, et al.
Nature Medicine|July 31, 2019
Clonal replacement of tumor-specific T cells following PD-1 blockadeKathryn E Yost, Ansuman T Satpathy, Daniel K Wells, et al.
Nature Genetics|October 27, 2020
Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer's and Parkinson's diseasesM Ryan Corces, Anna Shcherbina, Soumya Kundu, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Nature Communications|May 21, 2021
High-throughput single-cell chromatin accessibility CRISPR screens enable unbiased identification of regulatory networks in cancerSarah E Pierce, Jeffrey M Granja, William J Greenleaf
The Journal of Investigative Dermatology|October 14, 2018
Enhancer Connectome Nominates Target Genes of Inherited Risk Variants from Inflammatory Skin DisordersMark Y Jeng, Maxwell R Mumbach, Jeffrey M Granja, et al.
Nature Genetics|February 26, 2021
ArchR is a scalable software package for integrative single-cell chromatin accessibility analysisJeffrey M Granja, M Ryan Corces, Sarah E Pierce, et al.
Cell Reports|September 23, 2020
Chromatin Landscape Underpinning Human Dendritic Cell HeterogeneityRebecca Leylek, Marcela Alcántara-Hernández, Jeffrey M Granja, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2022
Polycomb-mediated genome architecture enables long-range spreading of H3K27 methylationKaterina Kraft, Kathryn E Yost, Sedona E Murphy, et al.
Nature Biotechnology|December 4, 2019
Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemiaJeffrey M Granja, Sandy Klemm, Lisa M McGinnis, et al.
Nature Cell Biology|August 3, 2021
LKB1 inactivation modulates chromatin accessibility to drive metastatic progressionSarah E Pierce, Jeffrey M Granja, M Ryan Corces, et al.
Nature Immunology|August 14, 2019
An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 developmentPrachi Bagadia, Xiao Huang, Tian-Tian Liu, et al.
Nature Medicine|July 31, 2019
Clonal replacement of tumor-specific T cells following PD-1 blockadeKathryn E Yost, Ansuman T Satpathy, Daniel K Wells, et al.
Nature Genetics|October 27, 2020
Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer's and Parkinson's diseasesM Ryan Corces, Anna Shcherbina, Soumya Kundu, et al.
Pageof 3